224 related articles for article (PubMed ID: 19202000)
41. Involvement of cyclo-oxygenase-1-mediated prostacyclin synthesis in the vasoconstrictor activity evoked by ACh in mouse arteries.
Liu B; Luo W; Zhang Y; Li H; Zhu N; Huang D; Zhou Y
Exp Physiol; 2012 Feb; 97(2):277-89. PubMed ID: 22080487
[TBL] [Abstract][Full Text] [Related]
42. A change in the redox environment and thromboxane A2 production precede endothelial dysfunction in mice.
Gendron ME; Thorin E
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2508-15. PubMed ID: 17644574
[TBL] [Abstract][Full Text] [Related]
43. Vascular endothelial function is improved by oral glycine treatment in aged rats.
Gómez-Zamudio JH; García-Macedo R; Lázaro-Suárez M; Ibarra-Barajas M; Kumate J; Cruz M
Can J Physiol Pharmacol; 2015 Jun; 93(6):465-73. PubMed ID: 25988540
[TBL] [Abstract][Full Text] [Related]
44. The role of endothelium in the vasorelaxant effects of the essential oil of Ocimum gratissimum in aorta and mesenteric vascular bed of rats.
Pires AF; Madeira SV; Soares PM; Montenegro CM; Souza EP; Resende AC; Soares de Moura R; Assreuy AM; Criddle DN
Can J Physiol Pharmacol; 2012 Oct; 90(10):1380-5. PubMed ID: 22716233
[TBL] [Abstract][Full Text] [Related]
45. Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin.
Gluais P; Lonchampt M; Morrow JD; Vanhoutte PM; Feletou M
Br J Pharmacol; 2005 Nov; 146(6):834-45. PubMed ID: 16158068
[TBL] [Abstract][Full Text] [Related]
46. Molecular basis for globotriaosylceramide regulation and enzyme uptake in immortalized aortic endothelial cells from Fabry mice.
Meng XL; Day TS; McNeill N; Ashcraft P; Frischmuth T; Cheng SH; Liu ZP; Shen JS; Schiffmann R
J Inherit Metab Dis; 2016 May; 39(3):447-455. PubMed ID: 26960552
[TBL] [Abstract][Full Text] [Related]
47. Endothelial nitric oxide attenuates Na+/Ca2+ exchanger-mediated vasoconstriction in rat aorta.
Zhao J; Majewski H
Br J Pharmacol; 2008 Jul; 154(5):982-90. PubMed ID: 18469841
[TBL] [Abstract][Full Text] [Related]
48. Alpha-galactosidase A in vascular disease.
Bodary PF; Shayman JA; Eitzman DT
Trends Cardiovasc Med; 2007 May; 17(4):129-33. PubMed ID: 17482095
[TBL] [Abstract][Full Text] [Related]
49. Proteomic analysis unveils Gb3-independent alterations and mitochondrial dysfunction in a gla
Elsaid HOA; Rivedal M; Skandalou E; Svarstad E; Tøndel C; Birkeland E; Eikrem Ø; Babickova J; Marti HP; Furriol J
J Transl Med; 2023 Sep; 21(1):591. PubMed ID: 37670295
[TBL] [Abstract][Full Text] [Related]
50. Endothelial dysfunction and improvement of the angiotensin II-reactivity in hypercholesterolemic rabbits: role of cyclooxygenase metabolites.
Jerez S; Sierra L; Coviello A; de Bruno MP
Eur J Pharmacol; 2008 Feb; 580(1-2):182-9. PubMed ID: 18053983
[TBL] [Abstract][Full Text] [Related]
51. Normal hearing in alpha-galactosidase A-deficient mice, the mouse model for Fabry disease.
Noben-Trauth K; Neely H; Brady RO
Hear Res; 2007 Dec; 234(1-2):10-4. PubMed ID: 17933476
[TBL] [Abstract][Full Text] [Related]
52. Increased globotriaosylceramide levels in a transgenic mouse expressing human alpha1,4-galactosyltransferase and a mouse model for treating Fabry disease.
Shiozuka C; Taguchi A; Matsuda J; Noguchi Y; Kunieda T; Uchio-Yamada K; Yoshioka H; Hamanaka R; Yano S; Yokoyama S; Mannen K; Kulkarni AB; Furukawa K; Ishii S
J Biochem; 2011 Feb; 149(2):161-70. PubMed ID: 20961863
[TBL] [Abstract][Full Text] [Related]
53. Restoration of endothelin-1-induced impairment in endothelium-dependent relaxation by interleukin-10 in murine aortic rings.
Zemse SM; Hilgers RH; Simkins GB; Rudic RD; Webb RC
Can J Physiol Pharmacol; 2008 Aug; 86(8):557-65. PubMed ID: 18758504
[TBL] [Abstract][Full Text] [Related]
54. Effect of celecoxib on cyclooxygenase-1-mediated prostacyclin synthesis and endothelium-dependent contraction in mouse arteries.
Liu B; Luo W; Zhang Y; Li H; Zhu N; Huang D; Zhou Y
Eur J Pharmacol; 2013 Jan; 698(1-3):354-61. PubMed ID: 23127498
[TBL] [Abstract][Full Text] [Related]
55. Sildenafil (Viagra®) Prevents Cox-1/ TXA2 Pathway-Mediated Vascular Hypercontractility in ApoE-/- Mice.
Leal MAS; Dias AT; Porto ML; Brun BF; Gava AL; Meyrelles SS; Gil-Longo J; Campos-Toimil M; Pereira TMC; Vasquez EC
Cell Physiol Biochem; 2017; 44(5):1796-1809. PubMed ID: 29216624
[TBL] [Abstract][Full Text] [Related]
56. Effect of tempol on altered angiotensin II and acetylcholine-mediated vascular responses in thoracic aorta isolated from rats with insulin resistance.
Viswanad B; Srinivasan K; Kaul CL; Ramarao P
Pharmacol Res; 2006 Mar; 53(3):209-15. PubMed ID: 16412660
[TBL] [Abstract][Full Text] [Related]
57. A new isoquinolinone derivative with noble vasorelaxation activity.
Lin CH; Lin MS; Lin YH; Chen IM; Lin PR; Cheng CY; Tsai MC
Pharmacology; 2003 Apr; 67(4):202-10. PubMed ID: 12595751
[TBL] [Abstract][Full Text] [Related]
58. Differences in cleavage of globotriaosylceramide and its derivatives accumulated in organs of young Fabry mice following enzyme replacement therapy.
Kodama T; Tsukimura T; Kawashima I; Sato A; Sakuraba H; Togawa T
Mol Genet Metab; 2017; 120(1-2):116-120. PubMed ID: 27756537
[TBL] [Abstract][Full Text] [Related]
59. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
Majithiya JB; Paramar AN; Balaraman R
Cardiovasc Res; 2005 Apr; 66(1):150-61. PubMed ID: 15769458
[TBL] [Abstract][Full Text] [Related]
60. Decreased nitric oxide bioavailability in a mouse model of Fabry disease.
Shu L; Park JL; Byun J; Pennathur S; Kollmeyer J; Shayman JA
J Am Soc Nephrol; 2009 Sep; 20(9):1975-85. PubMed ID: 19628671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
